NO832092L - Fremgangsmaate ved fremstilling av et heparinfragment - Google Patents
Fremgangsmaate ved fremstilling av et heparinfragmentInfo
- Publication number
- NO832092L NO832092L NO832092A NO832092A NO832092L NO 832092 L NO832092 L NO 832092L NO 832092 A NO832092 A NO 832092A NO 832092 A NO832092 A NO 832092A NO 832092 L NO832092 L NO 832092L
- Authority
- NO
- Norway
- Prior art keywords
- infragment
- health
- preparing
- procedure
- medicine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Polymers & Plastics (AREA)
- Biochemistry (AREA)
- Materials Engineering (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Saccharide Compounds (AREA)
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE8203611 | 1982-06-10 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO832092L true NO832092L (no) | 1983-12-12 |
| NO157783B NO157783B (no) | 1988-02-08 |
| NO157783C NO157783C (no) | 1988-05-18 |
Family
ID=20347038
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO832092A NO157783C (no) | 1982-06-10 | 1983-06-09 | Fremgangsmaate for fremstilling av et heparinfragment covalent bundet til antitrombin iii, og et mellomprodukt for fremstilling av heparinfragmentforbindelsen. |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US4623718A (no) |
| EP (1) | EP0098814B1 (no) |
| JP (1) | JPS5925802A (no) |
| AT (1) | ATE22899T1 (no) |
| CA (1) | CA1205011A (no) |
| DE (2) | DE98814T1 (no) |
| DK (1) | DK258283A (no) |
| NO (1) | NO157783C (no) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3422518A1 (de) * | 1984-06-16 | 1985-12-19 | B. Braun Melsungen Ag, 3508 Melsungen | Heparin-derivate, verfahren zu ihrer herstellung, diese enthaltende arzneimittel und ihre verwendung bei der behandlung von fettstoffwechselstoerungen |
| US4859581A (en) * | 1986-03-10 | 1989-08-22 | Board Of Regents, The University Of Texas System | Endoglycosidase assay |
| EP0337327A1 (en) * | 1988-04-09 | 1989-10-18 | Bioiberica, S.A. | Process for the preparation of new oligosaccharide fractions by controlled chemical depolimerization of heparin |
| US5252557A (en) * | 1988-07-25 | 1993-10-12 | Kiyoshi Kita | Administration method of antithrombin |
| US6562781B1 (en) * | 1995-11-30 | 2003-05-13 | Hamilton Civic Hospitals Research Development Inc. | Glycosaminoglycan-antithrombin III/heparin cofactor II conjugates |
| US6491965B1 (en) | 1995-11-30 | 2002-12-10 | Hamilton Civic Hospitals Research Development, Inc. | Medical device comprising glycosaminoglycan-antithrombin III/heparin cofactor II conjugates |
| US7045585B2 (en) | 1995-11-30 | 2006-05-16 | Hamilton Civic Hospital Research Development Inc. | Methods of coating a device using anti-thrombin heparin |
| US20040229778A1 (en) * | 2003-05-13 | 2004-11-18 | Elmaleh David R. | Pharmaceutical compositions of antithrombin III for the treatment of retroviral diseases |
| US7498130B2 (en) * | 2003-05-13 | 2009-03-03 | Massachusetts General Hospital | Method of reducing viral load |
| CA2535446A1 (en) * | 2003-08-12 | 2005-02-17 | Hamilton Civic Hospitals Research Development Inc. | Methods for preventing neurological events |
| CN103743837B (zh) * | 2013-12-24 | 2015-01-21 | 山东泰邦生物制品有限公司 | 人抗凝血酶ⅲ肝素结合比例检测方法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4301153A (en) | 1977-03-21 | 1981-11-17 | Riker Laboratories, Inc. | Heparin preparation |
| JPS6040859B2 (ja) | 1977-07-27 | 1985-09-12 | 喜温 三浦 | 抗血栓性人工医療材料 |
| CA1136620A (en) | 1979-01-08 | 1982-11-30 | Ulf P.F. Lindahl | Heparin fragments having selective anticoagulation activity |
| US4351938A (en) | 1980-05-19 | 1982-09-28 | Riker Laboratories, Inc. | Anticoagulant substance |
| ATE12779T1 (de) * | 1980-09-30 | 1985-05-15 | Bayer Ag | Verfahren zur herstellung eines antithrombinheparin-komplexes sowie diesen komplex enthaltende pharmazeutische mischungen. |
| US4446126A (en) | 1980-09-30 | 1984-05-01 | Cutter Laboratories, Inc. | Antithrombin-heparin complex and method for its production |
| US4386025A (en) | 1980-09-30 | 1983-05-31 | Cutter Laboratories, Inc. | Method of preparing antithrombin |
| JPS57134419A (en) | 1981-02-12 | 1982-08-19 | Eisai Co Ltd | Stable anticoagulant of blood |
| US4526714A (en) | 1982-12-13 | 1985-07-02 | Cordis Europa N.V. | Conjugates of anticoagulant and protein |
| US4533549A (en) | 1983-01-04 | 1985-08-06 | Lasker Sigmund E | Antithrombotic agent |
| US4689323A (en) | 1983-09-26 | 1987-08-25 | Miles Laboratories, Inc. | Covalently bound heparin--antithrombin-III complex |
-
1983
- 1983-05-24 AT AT83850140T patent/ATE22899T1/de not_active IP Right Cessation
- 1983-05-24 DE DE198383850140T patent/DE98814T1/de active Pending
- 1983-05-24 EP EP83850140A patent/EP0098814B1/en not_active Expired
- 1983-05-24 DE DE8383850140T patent/DE3366933D1/de not_active Expired
- 1983-06-07 DK DK258283A patent/DK258283A/da not_active Application Discontinuation
- 1983-06-08 CA CA000429939A patent/CA1205011A/en not_active Expired
- 1983-06-09 NO NO832092A patent/NO157783C/no unknown
- 1983-06-09 JP JP58101846A patent/JPS5925802A/ja active Pending
- 1983-06-10 US US06/503,105 patent/US4623718A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP0098814A1 (en) | 1984-01-18 |
| DK258283A (da) | 1983-12-11 |
| JPS5925802A (ja) | 1984-02-09 |
| EP0098814B1 (en) | 1986-10-15 |
| NO157783B (no) | 1988-02-08 |
| DE3366933D1 (en) | 1986-11-20 |
| NO157783C (no) | 1988-05-18 |
| CA1205011A (en) | 1986-05-27 |
| ATE22899T1 (de) | 1986-11-15 |
| DK258283D0 (da) | 1983-06-07 |
| US4623718A (en) | 1986-11-18 |
| DE98814T1 (de) | 1984-06-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3787403D1 (de) | Verwendung von spezifischen Monosacchariden zur Herstellung eines Arzneimittels zur Verhinderung von Metastasen maligner Tumore. | |
| ES8501414A1 (es) | Procedimiento de sintesis organica de oligosacaridos | |
| DE3650215D1 (de) | Orientiertes, silanvernetztes Polyäthylen-Produkt von ultrahohem Molekulargewicht und Verfahren zu dessen Herstellung. | |
| DE3166441D1 (en) | Novel antihistamines, process for their preparation and pharmaceutical compositions containing them | |
| ATE16591T1 (de) | Neue quartaere 6,11-dihydro-dibenzo-(b,e)-thiepin11-n-alkyl-norscopinether und verfahren zu deren herstellung. | |
| IL61708A0 (en) | Platinum(iv)diamine-complexes,a process for the preparation thereof,process for the preparation of a medicine using such a platinum(iv)-diamine-complex for the treatment of ccancer as well as the shaped medicine thus obtained | |
| DE3787459D1 (de) | Aminogruppenhaltige Polymerisate, ihre Herstellung und ihre Verwendung. | |
| BR8304973A (pt) | Mistura de polimero compativel | |
| FR2379553A1 (fr) | Nouveaux photoinducteurs de polymerisation, compositions photopolymerisables les contenant et procede de photopolymerisation | |
| HU896510D0 (en) | Novel anion-exchange polymers, process for preparing them and pharmaceutical compositions containing them | |
| NO832092L (no) | Fremgangsmaate ved fremstilling av et heparinfragment | |
| JPS5795916A (en) | Stabilization of vii factor activity in whole blood or blood plasma | |
| DE3484315D1 (de) | Messvorrichtung zur herstellung von nach mass hergestellten artikeln. | |
| FR2495154B1 (fr) | 5'-aminoalkyl-4', 4, 8-trialkylpsoralenes, leur procede de production et composition pharmaceutique les contenant | |
| DE59008005D1 (de) | Verfahren zur Herstellung von hochmolekularen Copolyarylensulfiden. | |
| PT88275A (pt) | Processo para a preparacao de composicoes farmaceuticas contendo 5-amino ou amino substituido-1,2,3-triazois uteis como agentes antiproliferativos | |
| JPS57167924A (en) | Chemokinesin and chemotaxin of leucocyte and inflammatory tissue | |
| BG40318A3 (bg) | Метод за получаване на имуноглобулинови производни на виндезина | |
| SE8704158D0 (sv) | Mikrosferer, forfarande for framstellning derav och anvendning derav | |
| ATE7139T1 (de) | N-aryl-n'-imidazol-2-yl-harnstoffe, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen. | |
| IL58103A0 (en) | Sila-substituted 1,4-dihydropyridine derivatives their production and pharmaceutical compositions containing them | |
| FI882278A0 (fi) | Parannettuja kromikatalyyttikoostumuksia ja polymerointimenetelmä, jossa niitä käytetään | |
| ATE30426T1 (de) | Peneme, sie enthaltende pharmazeutische zusammensetzungen und verfahren zu ihrer herstellung. | |
| FI891375L (fi) | Icke-vaevd, tygliknande produkt med anvaendande av ett bakteriecellulosabindemedel och foerfarande foer framstaellning av den. | |
| ATE86251T1 (de) | Polycyclische verbindungen, ihre herstellung und sie enthaltende rezepturen. |